Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Equinostic

Equinostic?uq=w9if130k
2005 FOUNDED
OOB STATUS
Out of Business LATEST DEAL TYPE
1 INVESTORS
Description

Provider of chemicals and apparatus designed to be used for acute phase protein determination. The company's chemicals and apparatuses focuses on on integrated diagnostic systems for inflammation markers called acute phase protein determination and blood analysis in the veterinary sector, enabling laboratories to conduct pathological tests using small amount of reagents that makes the tests economical to run.

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Biotechnology
Primary Office
  • Skovhegnet 10
  • 3460 Birkerød
  • Denmark

+45 61 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Equinostic’s full profile, request a free trial.

Equinostic Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Nov-2015 Completed Out of Business
1. Early Stage VC Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Equinostic Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Syddansk Innovation Accelerator/Incubator Minority 000 0000 000000 0

Equinostic Executive Team (2)

Name Title Board
Seat
Contact
Info
Peter Ottesen Director & Owner
Claus Andersson Ph.D Founder